249 related articles for article (PubMed ID: 27221916)
1. Sensitive and Noninvasive Detection of Aberrant SFRP2 and MGMT-B Methylation in Iranian Patients with Colon Polyps.
Naini MA; Mokarram P; Kavousipour S; Zare N; Atapour A; Zarin1 MH; Mehrabani G; Borji M
Asian Pac J Cancer Prev; 2016; 17(4):2185-93. PubMed ID: 27221916
[TBL] [Abstract][Full Text] [Related]
2. MGMT-B gene promoter hypermethylation in patients with inflammatory bowel disease - a novel finding.
Mokarram P; Kavousipour S; Sarabi MM; Mehrabani G; Fahmidehkar MA; Shamsdin SA; Alipour A; Naini MA
Asian Pac J Cancer Prev; 2015; 16(5):1945-52. PubMed ID: 25773792
[TBL] [Abstract][Full Text] [Related]
3. O6-Methyguanine-DNA Methyl Transferase (MGMT) Promoter Methylation in Serum DNA of Iranian Patients with Colorectal Cancer.
Alizadeh Naini M; Kavousipour S; Hasanzarini M; Nasrollah A; Monabati A; Mokarram P
Asian Pac J Cancer Prev; 2018 May; 19(5):1223-1227. PubMed ID: 29801405
[TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation of RASSF1A, MGMT, and HIC-1 genes in benign and malignant colorectal tumors.
Abouzeid HE; Kassem AM; Abdel Wahab AH; El-mezayen HA; Sharad H; Abdel Rahman S
Tumour Biol; 2011 Oct; 32(5):845-52. PubMed ID: 21274674
[TBL] [Abstract][Full Text] [Related]
5. Impact of catechol-O-methyltransferase gene variants on methylation status of P16 and MGMT genes and their downregulation in colorectal cancer.
Wani HA; Majid S; Bhat AA; Amin S; Farooq R; Bhat SA; Naikoo NA; Beigh MA; Kadla SA
Eur J Cancer Prev; 2019 Mar; 28(2):68-75. PubMed ID: 30379684
[TBL] [Abstract][Full Text] [Related]
6. KRAS, BRAF oncogene mutations and tissue specific promoter hypermethylation of tumor suppressor SFRP2, DAPK1, MGMT, HIC1 and p16 genes in colorectal cancer patients.
Bagci B; Sari M; Karadayi K; Turan M; Ozdemir O; Bagci G
Cancer Biomark; 2016 Jun; 17(2):133-43. PubMed ID: 27540971
[TBL] [Abstract][Full Text] [Related]
7. Promoter methylation of MGMT gene in serum of patients with esophageal squamous cell carcinoma in North East India.
Das M; Sharma SK; Sekhon GS; Saikia BJ; Mahanta J; Phukan RK
Asian Pac J Cancer Prev; 2014; 15(22):9955-60. PubMed ID: 25520135
[TBL] [Abstract][Full Text] [Related]
8. Serrated polyposis associated with a family history of colorectal cancer and/or polyps: The preferential location of polyps in the colon and rectum defines two molecular entities.
Silva P; Albuquerque C; Lage P; Fontes V; Fonseca R; Vitoriano I; Filipe B; Rodrigues P; Moita S; Ferreira S; Sousa R; Claro I; Nobre Leitão C; Chaves P; Dias Pereira A
Int J Mol Med; 2016 Sep; 38(3):687-702. PubMed ID: 27430658
[TBL] [Abstract][Full Text] [Related]
9. Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions.
Huang ZH; Li LH; Yang F; Wang JF
World J Gastroenterol; 2007 Feb; 13(6):950-4. PubMed ID: 17352030
[TBL] [Abstract][Full Text] [Related]
10. SFRP2 methylation in fecal DNA--a marker for colorectal polyps.
Oberwalder M; Zitt M; Wöntner C; Fiegl H; Goebel G; Zitt M; Köhle O; Mühlmann G; Ofner D; Margreiter R; Müller HM
Int J Colorectal Dis; 2008 Jan; 23(1):15-9. PubMed ID: 17639423
[TBL] [Abstract][Full Text] [Related]
11. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA
Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504
[TBL] [Abstract][Full Text] [Related]
12. MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers.
Shima K; Morikawa T; Baba Y; Nosho K; Suzuki M; Yamauchi M; Hayashi M; Giovannucci E; Fuchs CS; Ogino S
Cancer Causes Control; 2011 Feb; 22(2):301-9. PubMed ID: 21140203
[TBL] [Abstract][Full Text] [Related]
13. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS
Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591
[TBL] [Abstract][Full Text] [Related]
14. MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events.
de Vogel S; Weijenberg MP; Herman JG; Wouters KA; de Goeij AF; van den Brandt PA; de Bruïne AP; van Engeland M
Ann Oncol; 2009 Jul; 20(7):1216-22. PubMed ID: 19164452
[TBL] [Abstract][Full Text] [Related]
15. Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features.
Rosty C; Young JP; Walsh MD; Clendenning M; Walters RJ; Pearson S; Pavluk E; Nagler B; Pakenas D; Jass JR; Jenkins MA; Win AK; Southey MC; Parry S; Hopper JL; Giles GG; Williamson E; English DR; Buchanan DD
Mod Pathol; 2013 Jun; 26(6):825-34. PubMed ID: 23348904
[TBL] [Abstract][Full Text] [Related]
16. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Kim JH; Bae JM; Cho NY; Kang GH
Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
[TBL] [Abstract][Full Text] [Related]
17. KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype.
Kim KM; Lee EJ; Kim YH; Chang DK; Odze RD
Am J Surg Pathol; 2010 May; 34(5):667-75. PubMed ID: 20305537
[TBL] [Abstract][Full Text] [Related]
18. Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas.
Psofaki V; Kalogera C; Tzambouras N; Stephanou D; Tsianos E; Seferiadis K; Kolios G
World J Gastroenterol; 2010 Jul; 16(28):3553-60. PubMed ID: 20653064
[TBL] [Abstract][Full Text] [Related]
19. Metachronous serrated neoplasia is uncommon after right colectomy in patients with methylator colon cancers with a high degree of microsatellite instability.
Messick CA; Kravochuck S; Church JM; Kalady MF
Dis Colon Rectum; 2014 Jan; 57(1):39-46. PubMed ID: 24316944
[TBL] [Abstract][Full Text] [Related]
20. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA
Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
